Biostimulants Market to Reach $8.60 Billion by 2035 at 10.45% CAGR | Bayer, Syngenta, Corteva Agriscience Among Key Players

The global biostimulants market, valued at USD 2.88 billion in 2024, will reach USD 3.18 billion in 2025 and is forecast to hit USD 8.60 billion by 2035, advancing at a CAGR of 10.45% over the decade-long forecast period. Mounting pressure on conventional agrochemicals, accelerating adoption of organic farming, and supportive government policies across North America and Europe are converging to make biostimulants one of the most commercially compelling segments in the broader agricultural biologicals space. For investors, agribusinesses, and crop science companies tracking where the next wave of sustainable agriculture spending will land, this market is worth close attention.

To explore the complete findings, request a free sample of the report at https://www.rootsanalysis.com/reports/biostimulants-market/request-sample.html

MARKET OVERVIEW
Biostimulants are naturally derived substances or microorganisms applied to plants or the surrounding rhizosphere to activate the plant's own biological processes. Unlike fertilizers, which supply nutrients directly, or pesticides, which target pathogens, biostimulants enhance how plants absorb and use the nutrients already available to them. They improve nutrient uptake efficiency, build tolerance to abiotic stressors such as drought and extreme heat, and elevate overall crop quality and post-harvest performance. Biostimulants currently hold close to a 20% share of the wider agricultural biologicals market, and that share is growing.

The urgency behind this market's growth is not abstract. Decades of heavy agrochemical use have degraded soil health, harmed surrounding ecosystems, and raised legitimate concerns about food safety. Farmers across major growing regions are under regulatory and commercial pressure to reduce synthetic inputs, while simultaneously being asked to produce more food for an expanding global population. Biostimulants address both demands at once, which is why adoption is accelerating across crop types and geographies.

Policy support is adding further momentum. The United States Farm Bill provides a formal regulatory framework for biostimulants, classifying them alongside fertilizers and soil amendments for state-level oversight. In Europe, the EU's Farm to Fork strategy explicitly targets a reduction in synthetic chemical fertilizers, encouraging substitution with biological alternatives including biostimulants. These two regulatory environments, taken together, represent the largest and most mature demand bases for the products.

KEY GROWTH DRIVERS
Soil Health Deterioration and the Case Against Synthetic Inputs Years of intensive agrochemical application have significantly degraded arable soil quality globally. This degradation is now a commercial and policy problem, not merely an environmental one. As soil productivity declines, farmers need solutions that restore biological activity rather than compounding the problem. Biostimulants directly address this need by supporting microbial communities and organic matter cycles in degraded soils.

Organic Food Demand and Sustainable Farming Commitments Consumer preference for organic and residue-free food is translating into real purchasing shifts at the farm level. Growers seeking organic certification must reduce or eliminate synthetic crop protection inputs, creating a direct commercial pull for biological alternatives. This demand is especially pronounced in North America and Europe, where organic food retail has grown consistently for over a decade.
Government Initiatives and Regulatory Tailwinds Beyond the U.S. Farm Bill and the EU Farm to Fork strategy, government agencies are actively funding biostimulant production infrastructure. In January 2025, Worm Power secured a USD 900,000 USDA grant under the Fertilizer Production Expansion Program to scale its vermicomposting facility in Avon, New York. This type of direct public investment in biostimulant production signals institutional confidence in the category's long-term viability.

AI Integration and Precision Agriculture Applications Companies are now embedding artificial intelligence into biostimulant development and application. In January 2025, Syngenta partnered with TraitSeq to use TraitSeq's technology platform for identifying biomarkers that indicate plant responses to abiotic stresses, including drought and temperature extremes. The goal is to develop biostimulants that target specific stress conditions with greater precision, which reduces waste and improves field efficacy. This partnership model is increasingly common across the sector.

M&A Activity and Portfolio Expansion by Major Players Consolidation is accelerating as large crop science companies acquire specialized biostimulant innovators. In May 2025, ICL Group acquired Lavie Bio to strengthen its microbial-based biostimulant and biopesticide research capabilities. In December 2025, Ardabelle Capital and Capagro, supported by Sofiprotéol, announced a majority stake acquisition in Plymag. These transactions reflect a broader strategic shift among established agribusinesses toward biological crop inputs.

MARKET SEGMENTATION
The biostimulants market breaks down by source of product (microbes, plant extracts, and other sources), mode of application (foliar sprays, seed treatments, soil treatments, and other methods), type of crop treated (cereals and pulses, fruits and nuts, oilseeds, green fodder, vegetables and tubers, industrial crops, and textile crops), and geography. Among application modes, foliar sprays currently hold the largest market share. Their dominance reflects practical advantages in the field: nutrients and active biological compounds applied directly to leaves are absorbed faster, drive greater cellular activity, and deliver more immediate impact on nutrient uptake compared with soil-incorporated methods.

The fastest-growing application segment is seed treatments, which is projected to grow at close to 11% annually through 2035. Seed treatment adoption is rising because it enables precise, targeted delivery of biostimulant compounds at the point of germination, maximizing early plant development while minimizing product waste.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/biostimulants-market/request-quote.html

REGIONAL INSIGHTS
North America and Europe together accounted for over 60% of global biostimulant market share in 2025, with North America alone capturing approximately 40% of the total market. The region's leadership reflects a combination of strong farmer demand for biological crop solutions, a well-established organic farming sector, and a maturing regulatory framework that legitimizes and classifies biostimulants as a distinct product category. The United States, in particular, is home to a dense network of biostimulant manufacturers and distributors, and public grant funding from agencies like the USDA is actively building production capacity.

Europe follows closely, driven in large part by the EU Farm to Fork strategy, which has set binding targets for reductions in synthetic fertilizer use. European farmers operating under these targets are turning to biostimulants as a compliant and effective substitute, and the regulatory clarity is bringing institutional capital into the sector.

Asia-Pacific represents the market's most significant growth opportunity over the forecast period. The region will expand at a comparatively high CAGR, driven by rising demand for organic food products, growing farmer awareness of sustainable practices, and government initiatives supporting biological agricultural inputs. Most of the companies actively manufacturing biostimulants are currently based in Asia-Pacific, positioning the region as both a production hub and a rapidly expanding end market.

COMPETITIVE LANDSCAPE
The biostimulants market features a fragmented mix of large multinational crop science companies and specialized biological input firms. Key players profiled in the Roots Analysis report include Andermatt, Bayer, BioSafe Systems, Certis Biologicals, Corteva Agriscience, Novozymes, Nutri-Tech Solutions, ProFarm, Syngenta, and Valent Biosciences, among others.

The competitive dynamic is shifting. Large players like Bayer, Syngenta, and Corteva Agriscience are using acquisitions and technology partnerships to rapidly build biostimulant capabilities they do not yet have at scale internally, while specialist firms with deep biological science expertise are becoming attractive acquisition targets. The main battlegrounds are product efficacy differentiation, geographic distribution reach, and intellectual property around microbial strains and AI-assisted formulation technologies. New product launches are also a key competitive lever; in December 2025, Rovensa Next launched Myndra in Europe, a synergistic biostimulant targeting fruit quality and yield improvement, while Ocean Rainforest launched two seaweed-based biostimulants certified under USDA National Organic Program standards in August 2025.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/biostimulants-market.html

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.